{"data":{"id":"us-in/ic-16-42-24-10","jurisdiction":"us-in","citation":"IC 16-42-24-10","heading":"Use prohibition by health care facility facing loss of federal funding","body":"Sec. 10. If:\n(1) the federal government indicates that the federal government will withdraw all federal funds from a health care facility for allowing chymopapain to be used within the facility; and\n(2) providing or allowing use of chymopapain within the facility would jeopardize the receipt of:\n(A) federal funds for reimbursement for Medicare or Medicaid for all persons within the facility; or\n(B) construction funds provided by the federal government under the Hill-Burton Hospital Construction Program (42 U.S.C. 291 et seq.) or under Title XVI of the Public Health Services Act (42 U.S.C. 300q-300t);\nthe hospital or other health care facility may prohibit the use of chymopapain within the hospital or facility.","path":["TITLE 16. HEALTH","ARTICLE 42. REGULATION OF FOOD, DRUGS, AND COSMETICS","Chapter 24. Drugs: Use of Chymopapain"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-42-24-10","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"d7657cd5badf3eb1caad8757bbc68f74a723ad2bb16774bb5deeef2558d8c98e","source_id":"us-in","stale":false,"prev":"us-in/ic-16-42-24-9","next":"us-in/ic-16-42-25-1"},"notice":"GroundRules: Original legal text. Not legal advice."}